Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts
NCT ID: NCT02403206
Last Updated: 2018-07-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
406 participants
INTERVENTIONAL
2015-03-26
2016-08-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Venturi and Peristaltic Based Phacoemulsification in Femtosecond Laser Cataract Surgery
NCT03970525
Clinical Research of Femtosecond Laser-Assisted Cataract Surgery
NCT02492659
Posterior Capsulotomy in Cataract Complicated With Primary Posterior Capsule Opacification.
NCT03701139
Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With Cataracts
NCT06966167
Comparison of Femto-laser and Manually Created Clear Corneal Incisions During Cataract Surgery
NCT04082273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laser
Femtosecond laser assisted capsulotomy and corneal incision performed during cataract surgery
Femtosecond laser
Laser console and a patient interface used to cut tissue during cataract removal of the crystalline lens
Manual
Continuous curvilinear capsulorhexis performed during cataract surgery
Continuous Curvilinear Capsulorhexis (CCC)
Standard-of care manual procedure (using either needles or forceps) for creating capsulorhexis, ie., opening in capsular bag during anterior segment ophthalmic surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Femtosecond laser
Laser console and a patient interface used to cut tissue during cataract removal of the crystalline lens
Continuous Curvilinear Capsulorhexis (CCC)
Standard-of care manual procedure (using either needles or forceps) for creating capsulorhexis, ie., opening in capsular bag during anterior segment ophthalmic surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to lie flat in a supine position.
* Able to understand and willing to sign the Informed Consent Form (ICF).
* Presenting with intumescent white cataract, with a liquid pressurized bag and a milky, liquid cortex.
Exclusion Criteria
* Corneal disease that precludes application of the cornea or transmission of laser light at 1030 nanometer (nm) wavelength.
* Corneal opacity that would interfere with the laser beam.
* Presence of blood or other material in the anterior chamber.
* Hypotony or presence of corneal implant.
* Poorly dilating pupils.
* Condition which would cause inadequate clearance between the intended capsulotomy depth and the endothelium.
* Residual, recurrent, active ocular or eye lid disease, including any corneal abnormality.
* Any contraindication to cataract surgery.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon, a Novartis Company
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Manager, Surgical
Role: STUDY_DIRECTOR
Alcon, A Novartis Division
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CTW860-P001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.